Next Article in Journal
Anti-Inflammatory and Antiplatelet Activities of Plasma Are Conserved Across Twelve Mammalian Species
Previous Article in Journal
Cordycepin Induces S Phase Arrest and Apoptosis in Human Gallbladder Cancer Cells
Article

Hypoglycemic and Hypotensive Activity of a Root Extract of Smilax aristolochiifolia, Standardized on N-trans-Feruloyl-Tyramine

1
Centro de Investigación Biomédica del Sur, Instituto Mexicano del Seguro Social (IMSS), Argentina No. 1, C.P. 62790 Xochitepec, Morelos, Mexico
2
Programa de Doctorado de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana-Iztapalapa, Av. San Rafael Atlixco No. 186, Col. Vicentina C.P. 09340, Iztapalapa, México D.F., Mexico
3
Departamento de Farmacología, Universidad Autónoma Metropolitana-Iztapalapa, Av. San Rafael Atlixco No. 186, Col. Vicentina C.P. 09340, Iztapalapa, México D.F., Mexico
*
Author to whom correspondence should be addressed.
Molecules 2014, 19(8), 11366-11384; https://doi.org/10.3390/molecules190811366
Received: 17 June 2014 / Revised: 30 June 2014 / Accepted: 1 July 2014 / Published: 31 July 2014
(This article belongs to the Section Natural Products Chemistry)
The metabolic syndrome (MS) is a condition consisting of various metabolic abnormalities that are risk factors for developing kidney failure, cardiovascular, vascular and cerebrovascular diseases, among others. The prevalence of this syndrome shows a marked increase. The aim of this study was to investigate the pharmacological effect of Smilax aristolochiifolia root on some components of MS and obtain some of the active principle using chromatographic techniques. The compound isolated was N-trans-feruloyl tyramine NTF (1), and its structure was determined by spectroscopic and spectrometric analyses. The whole extract and the standardized fractions were able to control the weight gain around 30%; the fraction rich in NTF was able to decrease the hypertriglyceridemia by 60%. The insulin resistance decreased by approximately 40%; the same happened with blood pressure, since the values of systolic and diastolic pressure fell on average 31% and 37% respectively, to levels comparable to normal value. The treatment also had an immunomodulatory effect on the low-grade inflammation associated with obesity, since it significantly decreased the relative production of pro-inflammatory cytokines regarding anti-inflammatory cytokines, both kidney and adipose tissue. Therefore it can be concluded that the extract and fractions of Smilax aristolochiifolia root with NTF are useful to counteract some symptoms of MS in animal models. View Full-Text
Keywords: N-trans-feruloyl-tyramine; Smilax aristolochiifolia Smilacaceae; metabolic syndrome N-trans-feruloyl-tyramine; Smilax aristolochiifolia Smilacaceae; metabolic syndrome
Show Figures

Figure 1

MDPI and ACS Style

Amaro, C.A.B.; González-Cortazar, M.; Herrera-Ruiz, M.; Román-Ramos, R.; Aguilar-Santamaría, L.; Tortoriello, J.; Jiménez-Ferrer, E. Hypoglycemic and Hypotensive Activity of a Root Extract of Smilax aristolochiifolia, Standardized on N-trans-Feruloyl-Tyramine. Molecules 2014, 19, 11366-11384. https://doi.org/10.3390/molecules190811366

AMA Style

Amaro CAB, González-Cortazar M, Herrera-Ruiz M, Román-Ramos R, Aguilar-Santamaría L, Tortoriello J, Jiménez-Ferrer E. Hypoglycemic and Hypotensive Activity of a Root Extract of Smilax aristolochiifolia, Standardized on N-trans-Feruloyl-Tyramine. Molecules. 2014; 19(8):11366-11384. https://doi.org/10.3390/molecules190811366

Chicago/Turabian Style

Amaro, Carol A.B., Manasés González-Cortazar, Maribel Herrera-Ruiz, Rubén Román-Ramos, Lucia Aguilar-Santamaría, Jaime Tortoriello, and Enrique Jiménez-Ferrer. 2014. "Hypoglycemic and Hypotensive Activity of a Root Extract of Smilax aristolochiifolia, Standardized on N-trans-Feruloyl-Tyramine" Molecules 19, no. 8: 11366-11384. https://doi.org/10.3390/molecules190811366

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop